Human genes associated with SARS-CoV-2 infection
Keywords:
SARS-CoV-2, coronavirus infections, Covid-19, genetics, genetic predisposition to diseaseAbstract
Background:The clinical variability of SARS-CoV-2 infection is partially due to genetic factors.
Objective:To describe the main Covid-19 susceptibility genes.
Methodology:A literature review was performed in Google Scholar, SciELO, Annual Reviews and PubMed Central. The descriptors used to search the documents were consulted in DeCS: SARS-CoV-2, Covid-19, genetics and genetic predisposition to disease. Full text articles available in English and Spanish were selected, rather from peer-reviewed journals.
Results:Genes involved in SARS-CoV-2 infection include DDX1 which promotes viral replication, IFITM1, IFITM2, IFITM3, IFNAR2 encoding interferon-induced proteins, receptor genes (ACE2, ANPEP, DPP4), protease genes (TMPRSS2, furin, TMPRSS11D, CTSL, CTSB) that contribute to viral entry, immune response genes such as ABO and metallopeptidases such as the ADAM family. Risk genetic polymorphisms have been detected.
Conclusions:In SARS-CoV-2 infection, there is a complex interaction between environmental and genetic factors that determine the susceptibility of individuals to Covid and its severity. The role of genes in Covid-19 susceptibility should be further investigated.
Downloads
References
1. Conceicao C, Thakur N, Human S, Kelly JT, Logan L, Bialy D, et al. The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins. PLoS Biol [Internet]. 2020 [cited 2021 Nov 06];18(12):[approx.p.27. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751883/pdf/pbio.3001016.pdfç
2. Dobrindt K, Hoagland DA, Seah C, Kassim B, O'Shea CP, Murphy A, et al. Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection. Stem Cell Reports [Internet]. 2021 [cited 2021 Nov 06];16(3): 505-518. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881728/pdf/main.pdf
3. López-Farré A. Los genes de la susceptibilidad a la infección por Covid-19. An RANM [Internet]. 2020 [citado 17 Dic 2021];137(02):117-120. Disponible en: https://analesranm.es/wp-content/uploads/2020/numero_137_02/pdfs/rev04.pdf
4. Morales Peralta E, Alvarez Fornaris MA. Covid-19: aspectos relacionados a la susceptibilidad genética y defectos congénitos. Rev haban cienc méd [Internet]. 2020 [citado 17 Dic 2021];19(5):[approx.12p.]. Disponible en: http://scielo.sld.cu/pdf/rhcm/v19n5/1729-519X-rhcm-19-05-e3595.pdf
5. Daniloski Z, Jordan TX, Wessels HH, Hoagland DA, Kasela S, Legut M, et al. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells. Cell [Internet]. 2021 [cited 2021 Dec 17];184(1):92-105.e16. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584921/pdf/main.pdf
6. Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis. Trends Immunol. 2020 [cited 17 Dec 2021];41(12):1100-1115. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556779/pdf/main.pdf
7. Gill D, Arvanitis M, Carter P, Hernández Cordero AI, Jo B, et al. ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study. R Soc Open Sci [Internet]. 2020 [cited 2021 Dec 17]:7(11). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735342/pdf/rsos200958.pdf
8. Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, et al. Common, low-frequency, rare, and ultra-rare coding variants contribute to Covid-19 severity. Hum Genet [Internet]. 2021 [cited 2021 Dec 17];141(1):147-173. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661833/pdf/439_2021_Article_2397.pdf
9. Kasela S, Ortega VE, Martorella M, Garudadri S, Nguyen J, Ampleford E, et al. Genetic and non-genetic factors affecting the expression of Covid-19-relevant genes in the large airway epithelium. Genome Med [Internet]. 2021 [cited 2021 Nov 06];13(1):[approx.17p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059115/pdf/13073_2021_Article_866.pdf
10. Kucher AN, Babushkina NP, Sleptcov AA, Nazarenko MS. Genetic Control of Human Infection with SARS-CoV-2. Russ J Genet [Internet]. 2021 [cited 2021 Dec 17];7(6):627-641. Available from: https://link.springer.com/article/10.1134/S1022795421050057
11. Jahanafrooz Z, Chen Z, Bao J, Li H, Lipworth L, Guo X. An overview of human proteins and genes involved in SARS-CoV-2 infection. Gene [Internet]. 2021 [cited 2021 Dec 06];808:145963. Available from: https://doi.org/10.1016/j.gene.2021.145963
12. Zhang Q, Xiang R, Huo S, Zhou Y, Jiang S, Wang Q, et al. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct Target Ther [Internet]. 2021 [cited 2021 Dec 17];6:233. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193598/pdf/41392_2021_Article_653.pdf
13. Rodríguez Duque R, Miguel Soca PE. Farmacogenómica: principios y aplicaciones en la práctica médica. Rev haban cienc méd [Internet]. 2020 [citado 06 Nov 2021];19(6):e3128. Disponible en: http://scielo.sld.cu/pdf/rhcm/v19n6/1729-519X-rhcm-19-06-e3128.pdf
14. Sánchez-Artigas R, Díaz-Armas M, Rodríguez-Duque R, Miguel-Soca P. Principios y aplicaciones médicas de la edición de genes mediante CRISPR/Cas. Medisur [Internet]. 2021 [citado 06 Nov 2021];19(6):[aprox. 9 p.]. Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/5279/3643
15. Gaziano L, Giambartolomei C, Pereira AC, Gaulton A, Posner DC, Swanson SA, et al. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for Covid-19. Nat Med [Internet]. 2021 [cited 2021 Dec 17];27(4):668-676. Available from: https://www.nature.com/articles/s41591-021-01310-z.pdf
16. Pathak GA, Singh K, Miller-Fleming TW, Wendt FR, Ehsan N, Hou K, et al. Integrative genomic analyses identify susceptibility genes underlying Covid-19 hospitalization. Nat Commun [Internet]. 2021 [cited 2021 Dec 17] ;12(1):[approx. 11p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316582/pdf/41467_2021_Article_24824.pdf
17. Liu D, Yang J, Feng B, Lue W, Zhao C, Li L. Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of Covid-19. J Infect [Internet]. 2021 [cited 2021 Nov 06];82(1):126-132. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698677/pdf/main.pdf
18. Raskin S. Genetics of Covid-19. J Ped [Internet]. 2021 [cited 2021 Nov 06];97(4):378-386. Available from: https://jped.elsevier.es/en-pdf-S0021755720302114
19. Kadam SB, Sukhramani GS, Bishnoi P, Pable AA, Barvkar VT. SARS‐CoV‐2, the pandemic coronavirus: Molecular and structural insights. J Basic Microbiol [Internet]. 2021 [cited 2021 Dec 17];61(3):180-202. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013332/pdf/JOBM-61-180.pdf
20. Desimmie BA, Raru YY, Awadh HM, He P, Teka S, Willenburg KS. Insights intoSARS-CoV-2 Persistence and Its Relevance. Viruses [Internet]. 2021 [cited 2021 Nov 6];13(6):[approx.22p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013332/pdf/JOBM-61-180.pdf
21. Amanat F, Thapa M, Lei T, Ahmed SMS, Adelsberg DC, Carreño JM, et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell [Internet]. 2021 [cited 2021 Nov 06];184(15): 3936-3948. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185186/pdf/main.pdf
22. Expósito-Lara A, Feria-Díaz G, González-Benítez S, Miguel-Soca P. Variantes genéticas del SARS-CoV-2 y sus implicaciones clínicas. Medisan [Internet]. 2021 [citado 17 Dic 2021];25(6). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185186/pdf/main.pdf
23. Pacheco-Romero J. El enigma del coronavirus – Nueva variante ómicron – Nuevas inquietudes - La mujer. Rev peru ginecol obstet [Internet]. 2021 [citado 06 Dic 2021];67(4). Disponible en: http://51.222.106.123/index.php/RPGO/article/view/2380/2550
24. Zhu C, He G, Yin Q, Zeng L, Ye X, Shi Y, et al. Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge. J Med Virol [Internet]. 2021 [cited 2021 Dec 17];93(10):5729-5741. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27132
25. Díaz-Armas M, Sánchez-Artigas R, Matute-Respo T, Llumiquinga-Achi R. Proteína de la espícula del virus SARS-CoV-2 y su relación con la enzima convertidora de angiotensina-2. RIC [Internet]. 2021 [citado 06 Dic 2021];100 (5). Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/3633/4918
26. Yeung ML, Teng JLL, Jia L, Zhang C, Huang C, Cai J-P, et al. Soluble ACE2-mediated cell entry ofSARS-CoV-2 via interaction with proteinsrelated to the renin-angiotensin system. Cell [Internet]. 2021 [cited 2021 Dec 06];184(8): 2212-2228. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923941/pdf/main.pdf
27. Baranova A, Cao H, Zhang F. Unraveling Risk Genes of Covid-19 by Multi-Omics Integrative Analyses. Front Med (Lausanne) [Internet]. 2021 [cited 2021 Dec 17];8:[approx.8p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452849/pdf/fmed-08-738687.pdf
28. Liu Y, Hu G, Wang Y, Ren W, Zhao X, Ji F, et al. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2. Proc Natl Acad Sci U S A [Internet]. 2021 [cited 2021 Dec 17]; 118(12):[approx.9p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000431/pdf/pnas.202025373.pdf
29. Secolin R, de Araujo TK, Gonsales MC, Rocha CS, Naslavsky M, Marco L, et al. Genetic variability in Covid-19-related genes in the Brazilian population. Hum Genome Var [Internet]. 2021 [cited 2021 Dec 17];8:[approx.9p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017521/pdf/41439_2021_Article_146.pdf
30. Winstone H, Lista MJ, Reid AC, BoutonC, Pickering S, Galao RP, et al. The polybasiccleavage site in SARS-CoV-2 spike modulatesviral sensitivity to type I interferon and IFITM2. J Virol [Internet]. 2021 [cited 2021 Dec 06];95(9):e02422-20. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104117/pdf/JVI.02422-20.pdf
31. Vanderheiden A, Ralfs P, Chirkova T, Upadhyay AA, Zimmerman MG, Bedoya S, et al. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. J Virol [Internet]. 2020 [cited 2021 Dec 17];94(19):e00985-20. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495371/pdf/JVI.00985-20.pdfç
32. Carapito R, Li R, Helms J, Carapito C, Gujja S, Rolli V, et al. Identification of driver genes for critical forms of Covid-19 in a deeply phenotyped young patient cohort. Sci Transl Med. 2021[cited 2021 Dec 06]; 10:1126. Available from: https://www.science.org/doi/pdf/10.1126/scitranslmed.abj7521
33. Aljohmani A, Yildiz D. A Disintegrin and Metalloproteinase—Control Elements in Infectious Diseases. Front Cardiovasc Med [Internet]. 2020 [cited 2021 Dec 06];7: [approx.14p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772189/pdf/fcvm-07-608281.pdf
34. Covid-19 Host Genetics Initiative. Mapping the human genetic architecture of Covid-19. Nature [Internet]. 2021 [cited 2021 Dec 06];600(7889):472-477. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674144/pdf/41586_2021_Article_3767.pdf
35. Almaguer-Mederos L, Cuello-Almarales D, Almaguer-Gotay D. Rol de los genes ACE2 y TMPRSS2 en la susceptibilidad o gravedad de la Covid-19. Anales de la Academia de Ciencias de Cuba [Internet]. 2020 [citado 06 Dic 2021];10(2). Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/799/861
36. van Blokland IV, Lanting P, Ori APS, Vonk JM, Warmerdam RCA, Herkert JC, et al. Using symptom-based case predictions to identify host genetic factors that contribute to Covid-19 susceptibility. PLoS One [Internet]. 2021 [cited 2021 Dec 06];16(8):[approx.14p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357137/pdf/pone.0255402.pdf
37. Andolfo I, Russo R, Lasorsa VA, Cantalupo S, Rosato BE, Bonfiglio F, et al. Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe Covid-19. Science [Internet]. 2021 [cited 2021 Dec 06];24(4). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968217/pdf/main.pdf
38. Medina-Espitia ÓL, Mendoza-Beltrán F, Anaya-Almanza AM, Molano-Salazar ÓA. Covid-19 y metabolismo: una mirada más allá del sistema respiratorio y de la enfermedad trombótica. Rev Colomb Cardiol [Internet]. 2021 [citado 06/12/2021]; 28(4): 366-373. Disponible en: http://www.scielo.org.co/pdf/rcca/v28n4/0120-5633-rcca-28-4-366.pdf
39. Bermúdez-Garcell A, Serrano-Gámez N, Teruel-Ginés R, Sánchez-Sánchez R, Sigcho-Romero C. Mecanismos básicos de la epigenética. CCM [Internet]. 2020 [citado 06 Dic 2021];24(1). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/3448/1516
40. Al-Benna S. Association of high level gene expression of ACE2 in adipose tissue with mortality of Covid-19 infection in obese patients. Obes Med [Internet]. 2020 [cited 2021 Dec 17];9:[approx.5p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368415/pdf/main.pdf
41. Polverino F, Kheradmand F. Covid-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects. Front Med [Internet]. 2021 [cited 2021 Dec 17];7:[approx.8p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847987/pdf/fmed-07-627278.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Raisa Rodríguez Duque, Yarimi Rodríguez Moldón, María Teresa Díaz Armas
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
La revista GME tiene Acceso Abierto (Open Access) a su contenido bajo las premisas de que el libre acceso mejora el sistema de comunicación científica, lo cual elimina cualquier barrera que impida el acceso a la información y de que el mismo autor es el máximo beneficiario de este movimiento, al proporcionarle ventajas tanto en su aspecto económico, científico, como en servicios de valor añadido.
Los autores conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra; podrán establecer acuerdos adicionales para la distribución no exclusiva de la versión de la obra publicada en la revista, con el reconocimiento de haber sido publicado primero en esta revista.
Todo el contenido de esta revista se encuentra en Acceso Abierto, distribuido según los términos de la licencia Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) que permite el uso, distribución y reproducción no comerciales y sin restricciones en cualquier medio, siempre que sea debidamente citada la fuente primaria de publicación.
Download here;
